SuderNCWukichD. Prevalence of diabetic neuropathy in patients undergoing foot and ankle surgery. Foot Ankle Spec. 2012;5:97-101.
2.
AmetovASBarinovADyckPJ; SYDNEY Trial Study Group. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care. 2003;26:770-776.
3.
ZieglerDNowakHKemplerPVarghaPLowPA. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med. 2004;21:114-121.
4.
ZieglerDAmetovABarinovA. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care. 2006;29:2365-2370.
5.
VallianouNEvangelopoulosAKoutalasP. Alpha-lipoic acid and diabetic neuropathy. Rev Diabet Stud. 2009;6:230-236.
6.
RuessmannHJ, German Society of Outpatient Diabetes Centres AND (Arbeitsgemeinschaft niedergelassener diabetologisch tatiger Arzte e.V.). Switching from pathogenetic treatment with alpha-lipoic acid to gabapentin and other analgesics in painful diabetic neuropathy: a real-world study in outpatients. J Diabetes Complications. 2009;23:174-177.
7.
BertolottoFMassoneA. Combination of alpha lipoic acid and superoxide dismutase leads to physiological and symptomatic improvements in diabetic neuropathy. Drugs R D. 2012;12:29-34.
8.
Al-ZamilMK. The use of dipyridamole (curantyl) in combination with alpha-lipoic acid in the treatment of diabetic neuropathy with retinopathy. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108:23-26.
9.
NegrisanuGRosuMBolteBLefterDDabeleaD. Effects of 3-month treatment with the antioxidant alpha-lipoic acid in diabetic peripheral neuropathy. Rom J Intern Med. 1999;37:297-306.
10.
GibsonTMCotterMACameronNE. Effects of alpha-lipoic acid on impaired gastric fundus innervation in diabetic rats. Free Radic Biol Med. 2003;35:160-168.
